

Product description
von Hippel-Lindau tumor suppressor(VHL) Homo sapiens Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial
Source
Rabbit
Applications
IHC,ELISA
Reactivity
Human
Dilution
IHC 1:50-200, ELISA 1:10000-20000
Storage
-20°C/1 year
Specificity
The antibody detects endogenous VHL
Source/Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogen
The antiserum was produced against synthesized peptide derived from the N-terminal region of human VHL. AA range:1-50
Uniprot No
P40337
Alternative names
Von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL)
Form
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Clonality
Polyclonal
Background
von Hippel-Lindau tumor suppressor(VHL) Homo sapiens Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial
Other
Gene_name: VHL ; Protein_name: Von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL); Expression: Brain,Renal cell carcinoma,
Mol.Wt (Da)
24 kD
Concentration
1 mg/ml
-
Promotion
-
Order
-
Online message
-
Help center